New pill aims to ease burning nerve pain in diabetes patients
NCT ID NCT07159243
First seen Sep 30, 2025 · Last updated May 17, 2026 · Updated 28 times
Summary
This study tests an experimental pill called HL-1186 for people with diabetic peripheral neuropathic pain—nerve pain from diabetes. About 180 adults aged 18-75 with type 1 or 2 diabetes and at least 6 months of nerve pain will take either the drug or a placebo for 12 weeks. The main goal is to see if the drug lowers daily pain scores more than a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC PERIPHERAL NEUROPATHIC PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.